Skip to content
Screener

ArriVent BioPharma, Inc. AVBP Price / book

Price / book at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
7.2×+2.5×
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
3.4×+1.6×
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
49.5×+44.6×
Nuvation Bio logo
Nuvation BioNUVB
7.8×+5.9×
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
143.7×+142×
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
2.5×+1.0×

Other financials

Income statement

See full
Operating income-$46.1M+30.9%
Net income-$43.3M+32.7%
EPS (diluted)-$0.96+49.5%

Balance sheet

See full
Cash & equivalents$62.1M+24.5%
Total debt$419.0K+204%
Total equity$324.0M+60.0%
Total assets$349.3M+62.1%

Cash flow

See full
Operating cash flow-$41.9M+38.4%

Valuation

See full
Market cap$1.44B+106%
Enterprise value$1.38B+135%

Returns & leverage

See full
Return on equity-55.2%+8.0pp
Debt / equity0×0.0×
Current ratio14×-0.4×

Where this comes from

Calculated from ArriVent BioPharma, Inc.’s reported figures.

market cap/total stockholders equity=3.1×

Based on the most recent quarter.

The source filing: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026. Open the filing →

Filed
May 11, 2026, 4:08 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-058650

FAQ

What is ArriVent BioPharma, Inc.'s price / book?
ArriVent BioPharma, Inc. (AVBP) reported price / book of 3.1× in Q1 2026.
How has ArriVent BioPharma, Inc.'s price / book changed year-over-year?
ArriVent BioPharma, Inc.'s price / book increased by 1.4% year-over-year, from 3.1× to 3.1×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about ArriVent BioPharma, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude